Ubs Group Ag Bausch Health Companies Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ubs Group Ag holds 982,715 shares of BHC stock, worth $6.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

982,715

Previous 895,741 9.71%

Holding current value

$6.23 Million

Previous $5.8 Million 12.92%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.32 - $6.66 $375,727 - $579,246	86,974 Added 9.71%	982,715 $6.54 Million
Q1 2025 May 13, 2025	SELL	$6.16 - $7.94 $690,394 - $889,891	-112,077 Reduced 11.12%	895,741 $5.8 Million
Q4 2024 Feb 14, 2025	BUY	$7.34 - $9.78 $6.46 Million - $8.61 Million	880,027 Added 688.65%	1,007,818 $8.12 Million
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $401,908 - $635,970	-76,994 Reduced 37.6%	127,791 $1.04 Million
Q2 2024 Aug 13, 2024	BUY	$6.1 - $10.41 $424,993 - $725,275	69,671 Added 51.56%	204,785 $1.43 Million
Q1 2024 May 13, 2024	BUY	$7.77 - $10.61 $30,567 - $41,739	3,934 Added 3.0%	135,114 $1.43 Million
Q4 2023 Feb 09, 2024	SELL	$6.53 - $8.23 $1.72 Million - $2.16 Million	-263,052 Reduced 66.73%	131,180 $1.05 Million
Q3 2023 Nov 09, 2023	BUY	$7.69 - $9.71 $2.62 Million - $3.31 Million	341,213 Added 643.57%	394,232 $3.24 Million
Q2 2023 Aug 11, 2023	SELL	$5.72 - $8.8 $25.2 Million - $38.7 Million	-4,399,682 Reduced 98.81%	53,019 $424,000
Q1 2023 May 12, 2023	SELL	$6.28 - $9.85 $1.48 Million - $2.33 Million	-236,376 Reduced 5.04%	4,452,701 $36.1 Million
Q4 2022 Feb 08, 2023	BUY	$6.09 - $7.93 $15.6 Million - $20.4 Million	2,568,183 Added 121.09%	4,689,077 $29.4 Million
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $7.88 Million - $15.8 Million	1,720,637 Added 429.88%	2,120,894 $14.6 Million
Q2 2022 Aug 10, 2022	BUY	$7.06 - $23.63 $1.52 Million - $5.1 Million	215,902 Added 117.11%	400,257 $3.35 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $394,826 - $507,973	-18,279 Reduced 9.02%	184,355 $4.21 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $5.1 Million - $6.43 Million	-221,664 Reduced 52.24%	202,634 $5.6 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $3.19 Million - $3.83 Million	127,424 Added 42.92%	424,298 $11.8 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $388,216 - $462,803	-14,153 Reduced 4.55%	296,874 $8.71 Million
Q1 2021 May 12, 2021	SELL	$21.37 - $34.38 $74,303 - $119,539	-3,477 Reduced 1.11%	311,027 $9.87 Million
Q4 2020 Feb 11, 2021	SELL	$15.31 - $21.12 $838,498 - $1.16 Million	-54,768 Reduced 14.83%	314,504 $6.54 Million
Q3 2020 Nov 12, 2020	BUY	$14.88 - $20.13 $1.65 Million - $2.23 Million	110,873 Added 42.91%	369,272 $5.74 Million
Q2 2020 Jul 31, 2020	SELL	$13.31 - $20.51 $1.78 Million - $2.74 Million	-133,440 Reduced 34.05%	258,399 $4.73 Million
Q1 2020 May 01, 2020	SELL	$12.98 - $30.25 $868,699 - $2.02 Million	-66,926 Reduced 14.59%	391,839 $6.07 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $516,717 - $872,319	-27,354 Reduced 5.63%	458,765 $13.7 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $975,450 - $1.2 Million	46,717 Added 10.63%	486,119 $10.6 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $2.49 Million - $3.21 Million	121,521 Added 38.23%	439,402 $11.1 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $2.43 Million - $3.15 Million	-119,923 Reduced 27.39%	317,881 $7.85 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $3.79 Million - $6.08 Million	214,822 Added 96.34%	437,804 $8.09 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $4.6 Million - $5.72 Million	222,982 New	222,982 $5.72 Million

Others Institutions Holding BHC

# of Institutions

252

Shares Held

243M

Call Options Held

2.44M

Put Options Held

8.42M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.29B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account